Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Regulatory B Cells in Experimental Autoimmune Encephalomyelitis (EAE).
Occurrence of Psoriatic Arthritis during Interferon Beta 1a Treatment for Multiple Sclerosis.
CBRAIN: a web-based, distributed computing platform for collaborative neuroimaging research.
Autoantibodies in pre-clinical autoimmune disease.
Th22 cells are expanded in multiple sclerosis and are resistant to IFN-β
Masquerading optic neuritis.
A Fresh Look at the Potential Mechanisms of Progressive Muscle Relaxation Therapy on Depression in Female Patients With Multiple Sclerosis.
Multiple sclerosis: new measures to monitor the disease.
Conference Scene: Regulatory cells in autoimmunity: analyzing and moderating function.
Cost of care according to disease-modifying therapy in Mexicans with relapsing-remitting multiple sclerosis.
Hyaluronan Anchored to Activated CD44 on CNS Vascular Endothelial Cells Promotes Lymphocyte Extravasation in Experimental Autoimmune Encephalomyelitis.
Isolation, cryopreservation and culture of human amnion epithelial cells for clinical applications.
Interferon Beta and vitamin d synergize to induce immunoregulatory receptors on peripheral blood monocytes of multiple sclerosis patients.
Genetic polymorphisms related to vitamin D and the therapeutic potential of vitamin D in multiple sclerosis.
Viral exposures and MS outcome in a prospective cohort of children with acquired demyelination.
IFNγ Influences Type I Interferon Response and Susceptibility to Theiler's Virus-Induced Demyelinating Disease.
FTY720 inhibits tumor growth and enhances the tumor-suppressive effect of topotecan in neuroblastoma by interfering with the sphingolipid signaling pathway.
Evolutive study of relapsing-remitting multiple sclerosis with cervical proton magnetic resonance spectroscopy. A case report.
Burden of disease in multiple sclerosis patients with spasticity in Germany: mobility improvement study (Move I).
Use of botulinum toxin in individuals with neurogenic detrusor overactivity: State of the art review.
Multiple sclerosis in 2013: Novel triggers, treatment targets and brain atrophy measures.
Genetic pleiotropy between multiple sclerosis and schizophrenia but not bipolar disorder: differential involvement of immune-related gene loci.
Antibodies against interferon-beta in neuromyelitis optica patients.
Novartis: CHMP Issues Positive Opinion To Expand EU Label For Gilenya In RRMS
In vivo evidence of hippocampal dentate gyrus expansion in multiple sclerosis.

Pages